Abstract
To steal a memorable line up front: “Accounts of the Olivieri-Apotex-Sick Kids HospitalUniversity of Toronto controversy have multiplied and divided to the point where they would now over-fill the shelves of a reasonably sized library.” (1) But in the many contradictory accounts of this saga, none disagree about one point: that my colleagues and I, over these ten years, have opposed very influential forces. Those forces included: a powerful drug company; two successive Presidents and two successive Deans of Medicine (one of whom is now University of Toronto’s President) at Canada’s largest university; and the Boards and Administrations of a formerly highly prestigious children’s hospital.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
